유럽의 완제(Fill-Finish) 제조 시장 : 예측(2030년)-지역별 분석-제품별, 모달리티별, 최종 사용자별

The Europe fill finish manufacturing market was valued at US$ 2,473.26 million in 2022 and is expected to reach US$ 4,772.50 million by 2030; it is estimated to grow at a CAGR of 8.6% from 2022 to 2030.

Elevating Demand for Biologics Drives Europe Fill Finish Manufacturing Market

Biologics constitute a majority of the top-selling drugs, and they represent one of the fastest-growing pharmaceutical industry segments. Since the launch of recombinant protein-based therapies ~30 years ago, the overall biologics market has grown at an annual rate of more than 12%. Further, over 5,000 biopharmaceutical product candidates are currently under development. Although biopharmaceuticals offer significant profit margins, high development costs and complex production protocols are the key concerns of the sponsors of these pharmacological interventions. As a result, several start-ups and pharmaceutical giants have begun outsourcing different processes of their business operations to contract service providers. Moreover, outsourcing jobs to contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) reduces the requirement of capital investments, provides access to larger production capacities, decreases the time-to-market of products, and lowers risks associated with the commercialization of products.

Fill finish is the final step in the production process, and it is one of the most crucial stages of drug manufacturing. Biologics require special procedures and equipment for fill finish operations to ensure product integrity and safety. Thus, the rise in demand for biologics has resulted in an equivalent need for flexible aseptic fill finish technologies. Pharmaceutical drug manufacturers collaborate with contract service providers to leverage their experience and expertise in the latest fill finish technologies. Fill finish manufacturing services are currently provided by approximately 180 companies for a variety of biologics. They are located in over 350 fill finish factories for these contract manufacturing companies across various geographic regions.

Europe Fill Finish Manufacturing Market Overview

The market players in Germany are adopting organic and inorganic growth strategies for market expansion and growth. For instance, in July 2020, Vetter, the contract development and manufacturing organization (CDMO), headquarters in Ravensburg, Germany, announced that it is investing in additional fill/finish capacity with the purchase of a clinical manufacturing site in Austria.

Similarly, The Siegfried Group signed a cooperation and supply agreement with Biopharmaceutical New Technologies, a German immunotherapy company, for the large-scale filling and packaging of commercial quantities of BNT162b2, an innovative COVID-19 vaccine candidate. Following successful approval, the vaccine developed by BioNTech in cooperation with Pfizer, an American pharmaceutical company, will be filled by Siegfried at its Hameln site from mid-2021 onwards. Also, Rentschler Biotechnologie GmbH, leading contract development and manufacturing organization (CDMO) for biopharmaceuticals located in Germany, and Rentschler Fill Solutions GmbH, an independent specialist for aseptic fill and finish services, announced a strategic partnership to provide new state-of-the-art fill and finish facilities and one-stop solutions for biopharmaceutical products to meet the requirements of Rentschler Biotechnologie's clients.

Europe Fill Finish Manufacturing Market Revenue and Forecast to 2030 (US$ Million)

Europe Fill Finish Manufacturing Market Segmentation

The Europe fill finish manufacturing market is segmented based on product, modality, end user, and country. Based on product, the Europe fill finish manufacturing market is bifurcated into consumables and instruments. The consumables segment held a larger market share in 2022. Furthermore, the consumables is sub segmented into prefilled syringes, glass vial/plastic vials, cartridges, and others.

By modality, the Europe fill finish manufacturing market is segmented into recombinant proteins, monoclonal antibodies, vaccines, cell therapies and biological therapies, gene therapies, and others. The vaccines segment held the largest market share in 2022.

In terms of end user, the Europe fill finish manufacturing market is categorized into contract manufacturing organizations, biopharmaceutical companies, and others. The contract manufacturing organizations segment held the largest market share in 2022.

Based on country, the Europe fill finish manufacturing market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe fill finish manufacturing market share in 2022.

Becton Dickinson and Co, Gerresheimer AG, Groninger and Co GmbH, IMA Industria Macchine Automatiche SpA, Maquinaria Industrial Dara SL, Nipro Medical Europe NV, NNE AS, Optima Packaging Group Gmbh, Schott AG, SGD SA, Stevanato Group SpA, Syntegon Technology GmbH, and West Pharmaceutical Services Inc are some of the leading players operating in the Europe fill finish manufacturing market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Europe Fill Finish Manufacturing Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis

5. Europe Fill Finish Manufacturing Market - Key Industry Dynamics

• 5.1 Fill Finish Manufacturing Market - Key Industry Dynamics
• 5.2 Key Market Drivers
  • 5.2.1 Growing Adoption of Prefilled Syringes for Parenteral Administration
  • 5.2.2 Elevating Demand for Biologics
• 5.3 Key Market Restraints
  • 5.3.1 Growing Competition in Biopharmaceutical Contract Manufacturing Industry
• 5.4 Key Market Opportunities
  • 5.4.1 Significant Pipeline for Biologics
• 5.5 Key Future Trends
  • 5.5.1 Single-Use Systems for Aseptic Fill Finish
• 5.6 Impact of Drivers and Restraints:

6. Fill Finish Manufacturing Market - Europe Market Analysis

7. Europe Fill Finish Manufacturing Market Analysis - Product

• 7.1 Consumables
  • 7.1.1 Overview
  • 7.1.2 Consumables Market, Revenue and Forecast to 2030 (US$ Million)
• 7.2 Instruments
  • 7.2.1 Overview
  • 7.2.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)

8. Europe Fill Finish Manufacturing Market Analysis - Modality

• 8.1 Recombinant Proteins
  • 8.1.1 Overview
  • 8.1.2 Recombinant Proteins Market, Revenue and Forecast to 2030 (US$ Million)
• 8.2 Monoclonal Antibodies
  • 8.2.1 Overview
  • 8.2.2 Monoclonal Antibodies Market, Revenue and Forecast to 2030 (US$ Million)
• 8.3 Vaccines
  • 8.3.1 Overview
  • 8.3.2 Vaccines Market, Revenue and Forecast to 2030 (US$ Million)
• 8.4 Cell Therapies and Biological Therapies
  • 8.4.1 Overview
  • 8.4.2 Cell Therapies and Biological Therapies Market, Revenue and Forecast to 2030 (US$ Million)
• 8.5 Gene Therapies
  • 8.5.1 Overview
  • 8.5.2 Gene Therapies Market, Revenue and Forecast to 2030 (US$ Million)
• 8.6 Others
  • 8.6.1 Overview
  • 8.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. Europe Fill Finish Manufacturing Market Analysis - End User

• 9.1 Contract Manufacturing Organizations
  • 9.1.1 Overview
  • 9.1.2 Contract Manufacturing Organizations Market, Revenue and Forecast to 2030 (US$ Million)
• 9.2 Biopharmaceutical Companies
  • 9.2.1 Overview
  • 9.2.2 Biopharmaceutical Companies Market, Revenue and Forecast to 2030 (US$ Million)
• 9.3 Others
  • 9.3.1 Overview
  • 9.3.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

10. Europe Fill Finish Manufacturing Market - Country Analysis

• 10.1 Europe Fill Finish Manufacturing Market Breakdown, by Country
  • 10.1.1 United Kingdom
  • 10.1.2 United Kingdom Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
    • 10.1.2.1 United Kingdom Fill Finish Manufacturing Market Breakdown by Product
      • 10.1.2.1.1 United Kingdom Fill Finish Manufacturing Market Breakdown by Consumables
    • 10.1.2.2 United Kingdom Fill Finish Manufacturing Market Breakdown by Modality
    • 10.1.2.3 United Kingdom Fill Finish Manufacturing Market Breakdown by End User
  • 10.1.3 Germany
  • 10.1.4 Germany Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
    • 10.1.4.1 Germany Fill Finish Manufacturing Market Breakdown by Product
      • 10.1.4.1.1 Germany Fill Finish Manufacturing Market Breakdown by Consumables
    • 10.1.4.2 Germany Fill Finish Manufacturing Market Breakdown by Modality
    • 10.1.4.3 Germany Fill Finish Manufacturing Market Breakdown by End User
  • 10.1.5 France
  • 10.1.6 France Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
    • 10.1.6.1 France Fill Finish Manufacturing Market Breakdown by Product
      • 10.1.6.1.1 France Fill Finish Manufacturing Market Breakdown by Consumables
    • 10.1.6.2 France Fill Finish Manufacturing Market Breakdown by Modality
    • 10.1.6.3 France Fill Finish Manufacturing Market Breakdown by End User
  • 10.1.7 Italy
    • 10.1.7.1 Italy Fill Finish Manufacturing Market Breakdown by Product
      • 10.1.7.1.1 Italy Fill Finish Manufacturing Market Breakdown by Consumables
    • 10.1.7.2 Italy Fill Finish Manufacturing Market Breakdown by Modality
    • 10.1.7.3 Italy Fill Finish Manufacturing Market Breakdown by End User
  • 10.1.8 Spain
  • 10.1.9 Spain Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
    • 10.1.9.1 Spain Fill Finish Manufacturing Market Breakdown by Product
      • 10.1.9.1.1 Spain Fill Finish Manufacturing Market Breakdown by Consumables
    • 10.1.9.2 Spain Fill Finish Manufacturing Market Breakdown by Modality
    • 10.1.9.3 Spain Fill Finish Manufacturing Market Breakdown by End User
  • 10.1.10 Rest of Europe
  • 10.1.11 Rest of Europe Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
    • 10.1.11.1 Rest of Europe Fill Finish Manufacturing Market Breakdown by Product
      • 10.1.11.1.1 Rest of Europe Fill Finish Manufacturing Market Breakdown by Consumables
    • 10.1.11.2 Rest of Europe Fill Finish Manufacturing Market Breakdown by Modality
    • 10.1.11.3 Rest of Europe Fill Finish Manufacturing Market Breakdown by End User

11. Industry Landscape

• 11.1 Overview
• 11.2 Growth Strategies in the Fill Finish Manufacturing Market, 2020-2023
• 11.3 Inorganic Growth Strategies
  • 11.3.1 Overview
• 11.4 Organic Growth Strategies
  • 11.4.1 Overview

12. Company Profiles

• 12.1 IMA Industria Macchine Automatiche SpA
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
• 12.2 Nipro Medical Europe NV
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
• 12.3 Maquinaria Industrial Dara SL
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
• 12.4 Groninger and Co GmbH
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
• 12.5 SGD SA
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
• 12.6 Optima Packaging Group Gmbh
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
• 12.7 NNE AS
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Product & Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
• 12.8 Stevanato Group SpA
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
• 12.9 Syntegon Technology GmbH
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments
• 12.10 West Pharmaceutical Services Inc
  • 12.10.1 Key Facts
  • 12.10.2 Business Description
  • 12.10.3 Products and Services
  • 12.10.4 Financial Overview
  • 12.10.5 SWOT Analysis
  • 12.10.6 Key Developments
• 12.11 Gerresheimer AG
  • 12.11.1 Key Facts
  • 12.11.2 Business Description
  • 12.11.3 Products and Services
  • 12.11.4 Financial Overview
  • 12.11.5 SWOT Analysis
  • 12.11.6 Key Developments
• 12.12 Schott AG
  • 12.12.1 Key Facts
  • 12.12.2 Business Description
  • 12.12.3 Products and Services
  • 12.12.4 Financial Overview
  • 12.12.5 SWOT Analysis
  • 12.12.6 Key Developments
• 12.13 Becton Dickinson and Co
  • 12.13.1 Key Facts
  • 12.13.2 Business Description
  • 12.13.3 Products and Services
  • 12.13.4 Financial Overview
  • 12.13.5 SWOT Analysis
  • 12.13.6 Key Developments

13. Appendix

• 13.1 About Us
• 13.2 Glossary of Terms